Angi’s Earnings: A Preview

Angi (NASDAQ:ANGI) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors need…

Angi (NASDAQ:ANGI) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors need to know before the announcement.

Analysts estimate that Angi will report an earnings per share (EPS) of $-0.02.

Angi bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.02, which was followed by a 6.02% increase in the share price the next day.

Here’s a look at Angi’s past performance and the resulting price change:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.03 -0.02 -0.06 -0.04
EPS Actual -0.01 -0.03 -0.03 -0.06
Price Change % 6.02% -33.07% 19.6% -8.27%

eps graph

Stock Performance

Shares of Angi were trading at $2.47 as of February 09. Over the last 52-week period, shares are up 2.87%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Angi visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Antero Midstream Earnings Preview

Antero Midstream (NYSE:AM) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Antero Midstream will report an earnings per share (EPS) of $0.19.

AM

Read More

Recap: IDEAYA Biosciences Q2 Earnings

  IDEAYA Biosciences (NASDAQ:IDYA) reported its Q2 earnings results on Monday, August 15, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings IDEAYA Biosciences missed estimated earnings by 9.62%, reporting an EPS of $-0.57 versus an estimate of $-0.52. Revenue was down $2.90 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.05

IDYA